Erenumab
Modify Date: 2024-01-07 09:20:30
Erenumab structure
|
Common Name | Erenumab | ||
|---|---|---|---|---|
| CAS Number | 1582205-90-0 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of ErenumabErenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1]. |
| Name | Erenumab |
|---|
| Description | Erenumab is a fully human monoclonal antibody. Erenumab inhibits the calcitonin gene–related peptide (CGRP) receptor. Erenumab can be used for the prevention of episodic migraine[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |